Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
about
Topical acne treatments in Europe and the issue of antimicrobial resistance.Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat modelAzelaic acid (15% gel) in the treatment of acne rosacea.Hair loss and herbs for treatment.Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.Blood Trace Element Concentrations in Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MSBCL-2 and Bax Expression in Skin Flaps Treated with Finasteride or Azelaic Acid.Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome.Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne.A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation.
P2860
Q34462485-0C482C0B-696E-42C7-92C9-828069739201Q35843929-233E1D98-1CF7-4229-AD24-ECF4221DD3EEQ36808092-4D92A0BA-112C-4CA9-B64E-63B42CE33C01Q38132839-0400A891-8FB8-4D58-8914-92F4EBE33D67Q38698220-4F5E526D-8CFB-431D-870E-ABE23EAF22EFQ38865210-0A42E4A1-0ACD-47EC-86BE-EC09E417CC35Q41904419-F0BE3776-F3A4-4B1F-90D0-77731F2ECA4DQ42185137-F03E2D3E-4AB0-4156-B020-C15C4C677D81Q42519392-2E8DB43A-F00A-4727-860F-A331F7535DBCQ42733531-EE84617E-8961-4020-86F2-9E6A79E1B961Q43098459-1F6AFFDF-FC5A-49CB-BF77-6C785BAE3690Q50350822-7F27BE77-D7D6-4212-8217-2DF3622C077BQ51075020-ADC03ED7-9026-4CA3-83BE-9455694C8288Q54605231-45CAA1F4-521A-4A63-AA18-A1EE60E2B6BC
P2860
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@ast
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@en
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@nl
type
label
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@ast
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@en
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@nl
prefLabel
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@ast
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@en
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@nl
P2093
P2860
P1476
Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
@en
P2093
Bulteau-Portois MC
Mowszowicz I
Stamatiadis D
P2860
P304
P356
10.1111/J.1365-2133.1988.TB03474.X
P407
P577
1988-11-01T00:00:00Z